CIRSENTRA·LABS

About CIRSENTRA Labs

Every test in medicine is taken at rest. Almost everything that goes wrong happens after.

CIRSENTRA Labs is a research programme built on one question that no clinical test currently asks: what can this body still do the second time it is asked, and if the answer is less than the first time, which step failed.

Friederike Seiler

The mission

Medicine can tell you what is in a body. It cannot yet tell you what that body can do twice.

A blood panel, a scan, a biopsy. Each reports what is present in a patient who is lying still. That is an inventory of parts. It says nothing about whether those parts still work when the body is asked to do something, and nothing at all about whether they work the second time it is asked.

The distance between those two questions is not a technicality. It is where a great deal of modern medicine fails, and it fails in ways every clinician already recognises without having a name for what they share.

The first response tells you what the body did. The second tells you what the body became.

Why this has no name yet

Because it is not a molecule, an organ or a disease, it fell between the specialties that would each have owned a piece of it. Cardiology, oncology, neurology, endocrinology and immunology each hold one branch. The thing that connects them sat between five fields and inside none of them.

It is measurable. It has simply never been the thing that was measured.

What the missing measurement costs

Five failures, one gap. This is the size of it.

None of these is rare, and none of them is currently explained. Each is the same measurement missing at a different point.

The patient whose tests are normal
A 26-year-old clears a virus in four days and three months later cannot climb a flight of stairs without losing the weekend. Every resting test is normal, because the failure only appears after exertion, and exertion is the one condition no standard test creates. Post-viral illness, chronic fatigue and orthostatic intolerance affect millions of people who are tested at rest and told nothing is wrong.
The drug that binds and does nothing
A patient is target positive on every test, the drug reaches the target and binds it, and nothing happens. The target was counted, not tested. Counting confirms the label is there. It cannot tell you whether the population under that label still works, or still comes back after a dose. A large share of late-stage trial failure lives in this gap, in patients selected correctly by every criterion the field has.
The treatment that works and then stops
Eight good months, then the response goes. Often nothing measurable about the target or the tumour has changed. What ran out was the body's ability to rebuild the machinery between doses, and no schedule was ever set by that.
Recovery that is not recovery
Discharge criteria are met, the numbers are back to baseline, and the relapse arrives anyway. Baseline was measured at rest. The part that did not come back is only found by the next demand, which by then is an illness rather than a test.
Aging without a unit
Everyone agrees that people lose reserve with age. Nobody measures it. Resting values stay in range for decades while the margin behind them narrows, which is why an 80-year-old and a 40-year-old with identical bloods have nothing like the same outcome after the same operation.
Consequence

Same diagnosis, same drug, different outcome is a measurement gap, not a mystery.

What we are building

Find what the body can still do again. Name the step that failed. Repair that step instead of raising the dose.

The law

Why capacity changes at all

Every response a body makes runs one cycle of eight operations, and the next response inherits whatever the last one left behind. Training builds capacity. Sepsis spends it. Chronic infection misroutes it. Cancer takes it. We found the cycle and resolved it in adult human tissue.

The architecture

Where it is set in the body

A handful of brain sites face the blood directly, read what it carries, and set what the rest of the body does. They are where the state of the body becomes a command, and where a local problem becomes a whole-body one. The laboratory is named for them.

The measurement

How to see it in a patient

Which of the eight steps is limiting, in this patient, before the drug is chosen. Then the matched repair, and then the second demand, because a system is only restored if it can do the thing again.

What changes if this is right

Non-response stops being an unexplained outcome and becomes a named lesion with a matched repair. The patient whose tests are normal gets a test that is not normal. Relapse becomes something predicted rather than survived. Aging gets a unit, which is the slope of what does not come back across repeated demand. And a treatment sequence becomes checkable, because at the end of it the body either does the thing again or it does not.

And what does not

None of this replaces a diagnosis, and none of it is validated clinical practice yet. The measurement standards are entering validation. We say which rung of that ladder we have actually climbed, on the programme page, and no claim on this site runs ahead of it.

The people

One programme, and the collaborators it is built with.

The discovery and the integration are CIRSENTRA's own. The science is strengthened by senior collaborators across several countries and disciplines, and the work converges on one interface.

Friederike Seiler

Computational biomedicine and medical data science

Wrote the curriculum and recruited the faculty of a private medical school in Vienna, then concluded that the siloed structure of medical training could not ask the questions chronic disease demands.

Built the integration platform the laboratory runs on, and was the first to identify the circumventricular sentinel network in adult-human data.

Jan Potempa

Microbial proteases and host-pathogen biochemistry

A leading authority on the proteolytic biology of Porphyromonas gingivalis. His work defined the gingipains, the arginine and lysine specific cysteine proteases the organism uses to degrade host proteins, disable complement and drive periodontal and systemic disease.

His laboratories at Jagiellonian University in Kraków and the University of Louisville study how bacterial proteolysis reshapes host biology, work that now reaches from the oral cavity to the proteolytic link with Alzheimer disease. Those decades of biochemistry are the foundation the therapeutic programme is built on.

Lukas Prantl

Regenerative medicine and stem-cell research

Head of the Department of Plastic, Hand and Reconstructive Surgery at University Hospital Regensburg, where he founded the Applied Stem Cell Research Center. His group studies adipose-derived stem cells and cell-enriched lipotransfer for tissue regeneration and wound healing, across more than 300 peer-reviewed papers.

Past President of the German Society of Plastic, Reconstructive and Aesthetic Surgeons and President-elect of the German Society of Surgery, he anchors the collaboration's clinical and translational side.

How we work

Five rules, and each one has cost us a result.

That is what they are for. A rule that never removes anything is decoration.

Open inputs, original integration
The data that matters is already public. The hard part is the original thinking that connects it across disciplines, and then publishing the framework so others can check it.
Human data first
Causality in humans, not animals. Model systems fix mechanism, and mechanism does not transfer on its own. Where a result is mouse or peripheral tissue, we say so in the sentence that uses it.
Exact denominators
Donor counts, cell counts and cohort sizes travel with every number, and it is always stated whether the analysis is ours or the source's. A count without a denominator is not evidence.
The direction goes first
A prediction written down before the data are opened is worth more than a fit found afterwards. All three completed tests were specified in that order, and one of them survived having its direction reversed.
Falsifiable by design
Every discovery ships with the experiment that would refute it, and a mechanism inherits its lowest unresolved layer rather than its strongest. Unresolved questions are counted and published, because a body of work that reports only its resolved fraction is reporting a selection.

Contact

Write to me.

One address, read by the person who will answer it.

fs@cirsentra.com

What is useful to send

Scientists. Take the falsifier list and try to end the thing. That is a service, and it is faster than agreement.

Clinicians. Tell us which of the five failures you see most, and in which patients.

Partners. Bring a target that failed in target-positive patients.

Start with the science or the programme, depending on which question you came with.